DARE-HRT1
Localized hormone therapy for Genitourinary Syndrome of Menopause (GSM)
PreclinicalActive
Key Facts
Indication
Localized hormone therapy for Genitourinary Syndrome of Menopause (GSM)
Phase
Preclinical
Status
Active
Company
About Dare Bioscience
Dare Bioscience, Inc. is a mission-driven company committed to addressing significant unmet needs in women's health through the development of novel, localized therapeutics. Its strategy centers on proprietary technology platforms designed to deliver drugs directly to the site of action, aiming to improve efficacy and safety profiles. The company's lead assets target large market opportunities in contraception and bacterial vaginosis, positioning it in a high-need, underserved therapeutic area. As a public entity, Dare faces the dual challenge of executing on clinical milestones while navigating the capital-intensive biotech landscape.
View full company profile